Manganese(II) oxide that the Mn ions form a face centered cubic magnetic sub-lattice where there are ferromagnetically coupled sheets that are anti-parallel with adjacent sheets. Manganese(II) oxide undergoes the chemical reactions typical of an ionic oxide. Upon treatment with acids, it converts to the corresponding manganese(II) salt and water. Oxidation of manganese(II) oxide gives manganese(III) oxide. MnO occurs in nature as the rare mineral manganosite. Commercially it is prepared by reduction of MnO with hydrogen, carbon monoxide or methane, e.g.: MnO can also be prepared by decarbonation of the carbonate: This calcining process is conducted anaerobically, lest MnO form. An alternative route,
Manganese broad-spectrum plant fertilizers contain manganese. The U.S. Institute of Medicine (IOM) updated Estimated Average Requirements (EARs) and Recommended Dietary Allowances (RDAs) for minerals in 2001. For manganese there was not sufficient information to set EARs and RDAs, so needs are described as estimates for Adequate Intakes (AIs). As for safety, the IOM sets Tolerable upper intake levels (ULs) for vitamins and minerals when evidence is sufficient. In the case of manganese the adult UL is set at 11 mg/day. Collectively the EARs, RDAs, AIs and ULs are referred to as Dietary Reference Intakes (DRIs). Manganese deficiency is rare. The European